Ropeginterferon Alfa 2b for Early MyelofibrosisDIPSS Low/Intermediate-1 Risk Myelofibrosis

Clinical trial NCT05731245 · RECRUITING

Trial details

NCT number: NCT05731245
Sponsor: National Taiwan University Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pre-fibrotic Myelofibrosis

Start date: 2023-02-08
Primary completion: 2024-10-12
Enrollment: 50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.